14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level

      research-article
      a , c , d , 1 , a , 1 , a , c , d , a , c , d , * , b , ** , a , **
      Redox Biology
      Elsevier
      CHX, cycloheximide, CLP, cecal ligation and puncture, COX-2, prostaglandin H2 synthase, GCL, γ-glutamylcysteine ligase, GSH, glutathione, GSS, glutathione synthetase, HMGB1, high mobility group box 1, IL-1β, interleukin-1 beta, iNOS, inducible nitric oxide synthases, LPS, Lipopolysaccharide, NAC, N-acetyl-L-cysteine, NF-κB, nuclear factor-kappa B, NO, nitric oxide, Nrf2, nuclear factor-erythroid 2-related factor, ROS, reactive oxygen species, TNF-α, tumor necrosis factor-α, γ-GC, γ-glutamylcysteine, γ-GT, γ-glutamyltranspeptidase, γ-glutamylcysteine, Sepsis, Glutathione, N-acetyl-L-cysteine, Glutathione synthetase

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection and characterized by redox imbalance and severe oxidative stress. Glutathione (GSH) serves several vital functions, including scavenging free radicals and maintaining intracellular redox balance. Extracellular GSH is unable to be taken into the majority of human cells, and the GSH prodrug N-acetyl- l-cysteine (NAC) does not exhibit promising clinical effects. γ-glutamylcysteine (γ-GC), an intermediate dipeptide of the GSH-synthesis pathway and harboring anti-inflammatory properties, represents a relatively unexplored option for sepsis treatment. The anti-inflammatory efficiency of γ-GC and the associated molecular mechanism need to be explored. In vivo investigation showed that γ-GC reduced sepsis lethality and attenuated systemic inflammatory responses in mice, as well as inhibited lipopolysaccharide (LPS)-stimulated production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), high-mobility group box 1 (HMGB1), and nitric oxide (NO) and the expression of inducible NO synthase and cyclooxygenase 2 in RAW264.7 cells. Moreover, both in vivo and in vitro experiments demonstrated that γ-GC exhibited better therapeutic effects against inflammation compared with N-acetyl- L-cysteine (NAC) and GSH. Mechanistically, γ-GC suppressed LPS-induced reactive oxygen species accumulation and GSH depletion. Inflammatory stimuli, such as LPS treatment, upregulated the expression of glutathione synthetase via activating nuclear factor-erythroid 2-related factor (Nrf2) and nuclear factor kappa B (NF-κB) pathways, thereby promoting synthesis of GSH from γ-GC. These findings suggested that γ-GC might represent a potential therapeutic agent for sepsis treatment.

          Graphical abstract

          Highlights

          • γ-GC reduces sepsis lethality and attenuates inflammatory responses in BALB/c mice.

          • γ-GC suppresses LPS-induced inflammation, ROS accumulation, and GSH depletion.

          • Nrf2 and NF-κB pathways are essential for upregulating GSS level to promote GSH synthesis from γ-GC.

          • γ-GC is more effective in attenuation inflammation than NAC and GSH.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          iNOS-mediated nitric oxide production and its regulation.

          This review focuses on the production of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) and its regulation under physiological and pathophysiological conditions. NO is an important biological mediator in the living organism that is synthesized from L-arginine using NADPH and molecular oxygen. However, the overproduction of NO which is catalyzed by iNOS, a soluble enzyme and active in its dimeric form, is cytotoxic. Immunostimulating cytokines or bacterial pathogens activate iNOS and generate high concentrations of NO through the activation of inducible nuclear factors, including NFkB. iNOS activation is regulated mainly at the transcriptional level, but also at posttranscriptional, translational and postranslational levels through effects on protein stability, dimerization, phosphorylation, cofactor binding and availability of oxygen and L-arginine as substrates. The prevention of the overproduction of NO in the living organism through control of regulatory pathways may assist in the treatment of high NO-mediated disorders without changing physiological levels of NO. Copyright 2004 Elsevier Inc.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Glutathione dysregulation and the etiology and progression of human diseases.

            Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and as a result, disturbances in GSH homeostasis are implicated in the etiology and/or progression of a number of human diseases, including cancer, diseases of aging, cystic fibrosis, and cardiovascular, inflammatory, immune, metabolic, and neurodegenerative diseases. Owing to the pleiotropic effects of GSH on cell functions, it has been quite difficult to define the role of GSH in the onset and/or the expression of human diseases, although significant progress is being made. GSH levels, turnover rates, and/or oxidation state can be compromised by inherited or acquired defects in the enzymes, transporters, signaling molecules, or transcription factors that are involved in its homeostasis, or from exposure to reactive chemicals or metabolic intermediates. GSH deficiency or a decrease in the GSH/glutathione disulfide ratio manifests itself largely through an increased susceptibility to oxidative stress, and the resulting damage is thought to be involved in diseases, such as cancer, Parkinson's disease, and Alzheimer's disease. In addition, imbalances in GSH levels affect immune system function, and are thought to play a role in the aging process. Just as low intracellular GSH levels decrease cellular antioxidant capacity, elevated GSH levels generally increase antioxidant capacity and resistance to oxidative stress, and this is observed in many cancer cells. The higher GSH levels in some tumor cells are also typically associated with higher levels of GSH-related enzymes and transporters. Although neither the mechanism nor the implications of these changes are well defined, the high GSH content makes cancer cells chemoresistant, which is a major factor that limits drug treatment. The present report highlights and integrates the growing connections between imbalances in GSH homeostasis and a multitude of human diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis

              Increasing evidence suggests the important role of metabolic reprogramming in the regulation of the innate inflammatory response, but the underlying mechanism remains unclear. Here, we provide evidence to support a novel role for the pyruvate kinase M2 (PKM2)-mediated Warburg effect, namely aerobic glycolysis, in the regulation of high mobility group box 1 (HMGB1) release. PKM2 interacts with hypoxia-inducible factor 1α (HIF1α) and activates the HIF-1α-dependent transcription of enzymes necessary for aerobic glycolysis in macrophages. Knockdown of PKM2, HIF1α, and glycolysis-related genes uniformly decreases lactate production and HMGB1 release. Similarly, a potential PKM2 inhibitor, shikonin, reduces serum lactate and HMGB1 levels and protects mice from lethal endotoxemia and sepsis. Collectively, these findings shed light on a novel mechanism for metabolic control of inflammation by regulating HMGB1 release and highlight the importance of targeting aerobic glycolysis in the treatment of sepsis and other inflammatory diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                26 September 2018
                January 2019
                26 September 2018
                : 20
                : 157-166
                Affiliations
                [a ]State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, Jiangsu, China
                [b ]Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing 210046, Jiangsu, China
                [c ]Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, Jiangsu, China
                [d ]Laboratory of Cellular and Molecular Biology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, Jiangsu, China
                Author notes
                [* ]Corresponding author at: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, Jiangsu, China. caopeng@ 123456jsatcm.com
                [1]

                These authors have contributed equally to this work.

                Article
                S2213-2317(18)30836-X
                10.1016/j.redox.2018.09.019
                6197438
                30326393
                1344c3c9-81c0-4768-961e-3c091c1da582
                © 2018 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 10 September 2018
                : 25 September 2018
                Categories
                Research Paper

                chx, cycloheximide,clp, cecal ligation and puncture,cox-2, prostaglandin h2 synthase,gcl, γ-glutamylcysteine ligase,gsh, glutathione,gss, glutathione synthetase,hmgb1, high mobility group box 1,il-1β, interleukin-1 beta,inos, inducible nitric oxide synthases,lps, lipopolysaccharide,nac, n-acetyl-l-cysteine,nf-κb, nuclear factor-kappa b,no, nitric oxide,nrf2, nuclear factor-erythroid 2-related factor,ros, reactive oxygen species,tnf-α, tumor necrosis factor-α,γ-gc, γ-glutamylcysteine,γ-gt, γ-glutamyltranspeptidase,γ-glutamylcysteine,sepsis,glutathione,n-acetyl-l-cysteine,glutathione synthetase

                Comments

                Comment on this article